The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Drug Therapy, Combination

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Drug Therapy, Combination


Psychiatry related information on Drug Therapy, Combination


High impact information on Drug Therapy, Combination


Chemical compound and disease context of Drug Therapy, Combination


Biological context of Drug Therapy, Combination


Anatomical context of Drug Therapy, Combination


Associations of Drug Therapy, Combination with chemical compounds


Gene context of Drug Therapy, Combination


Analytical, diagnostic and therapeutic context of Drug Therapy, Combination


  1. An evaluation of early or delayed adjuvant chemotherapy in premenopausal patients with advanced breast cancer undergoing oophorectomy. Ahmann, D.L., O'Connell, M.J., Hahn, R.G., Bisel, H.F., Lee, R.A., Edmonson, J.H. N. Engl. J. Med. (1977) [Pubmed]
  2. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. Fisher, R.I., Gaynor, E.R., Dahlberg, S., Oken, M.M., Grogan, T.M., Mize, E.M., Glick, J.H., Coltman, C.A., Miller, T.P. N. Engl. J. Med. (1993) [Pubmed]
  3. Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy. Young, R.C., Chabner, B.A., Hubbard, S.P., Fisher, R.I., Bender, R.A., Anderson, T., Simon, R.M., Canellos, G.P., DeVita, V.T. N. Engl. J. Med. (1978) [Pubmed]
  4. Gynecomastia and gonadal dysfunction in adolescent boys treated with combination chemotherapy for Hodgkin's disease. Sherins, R.J., Olweny, C.L., Ziegler, J.L. N. Engl. J. Med. (1978) [Pubmed]
  5. Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No. 75. Zacharski, L.R., Henderson, W.G., Rickles, F.R., Forman, W.B., Cornell, C.J., Forcier, R.J., Edwards, R., Headley, E., Kim, S.H., O'Donnell, J.R., O'Dell, R., Tornyos, K., Kwaan, H.C. JAMA (1981) [Pubmed]
  6. A strategy of "combination chemotherapy" in Alzheimer's disease: rationale and preliminary results with physostigmine plus deprenyl. Sunderland, T., Molchan, S., Lawlor, B., Martinez, R., Mellow, A., Martinson, H., Putnam, K., Lalonde, F. International psychogeriatrics / IPA. (1992) [Pubmed]
  7. Bladder cancer: twenty years of progress and the challenges that remain. Lamm, D.L. CA: a cancer journal for clinicians. (1998) [Pubmed]
  8. Combination chemotherapy for ITP. Kao, N.L., Richmond, G.W. N. Engl. J. Med. (1993) [Pubmed]
  9. Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon. Foon, K.A., Sherwin, S.A., Abrams, P.G., Longo, D.L., Fer, M.F., Stevenson, H.C., Ochs, J.J., Bottino, G.C., Schoenberger, C.S., Zeffren, J. N. Engl. J. Med. (1984) [Pubmed]
  10. Tamoxifen. Use in treatment of metastatic breast cancer refractory to combination chemotherapy. Legha, S.S., Buzdar, A.U., Hortobagyi, G.N., Wiseman, C., Benjamin, R.S., Blumenschein, G.R. JAMA (1979) [Pubmed]
  11. Differentiation-linked secretion of urokinase and tissue plasminogen activator by normal human hemopoietic cells. Wilson, E.L., Francis, G.E. J. Exp. Med. (1987) [Pubmed]
  12. Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine. Chahinian, P.A., Arnold, D.J., Cohen, J.M., Purpora, D.P., Jaffrey, I.S., Teirstein, A.S., Kirschner, P.A., Holland, J.F. JAMA (1977) [Pubmed]
  13. Cisplatin-based combination chemotherapy in the treatment of advanced-stage testicular cancer: cost-benefit analysis. Shibley, L., Brown, M., Schuttinga, J., Rothenberg, M., Whalen, J. J. Natl. Cancer Inst. (1990) [Pubmed]
  14. Phase II evaluation of carboplatin in advanced endometrial carcinoma. Long, H.J., Pfeifle, D.M., Wieand, H.S., Krook, J.E., Edmonson, J.H., Buckner, J.C. J. Natl. Cancer Inst. (1988) [Pubmed]
  15. Phase I/II study of cyclophosphamide, doxorubicin, fluorouracil, and leucovorin for treatment of metastatic adenocarcinoma. Parnes, H.L., Abrams, J.S., Tait, N., Minford, J., Allen, S.L., Duggan, D., Aisner, J. J. Natl. Cancer Inst. (1991) [Pubmed]
  16. Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) in previously treated ovarian cancer patients. Lund, B., Hansen, O.P., Theilade, K., Hansen, M., Neijt, J.P. J. Natl. Cancer Inst. (1994) [Pubmed]
  17. Ondansetron versus ondansetron, dexamethasone, and chlorpromazine in the prevention of nausea and vomiting associated with multiple-day cisplatin chemotherapy. Fox, S.M., Einhorn, L.H., Cox, E., Powell, N., Abdy, A. J. Clin. Oncol. (1993) [Pubmed]
  18. Roscovitine modulates DNA repair and senescence: implications for combination chemotherapy. Crescenzi, E., Palumbo, G., Brady, H.J. Clin. Cancer Res. (2005) [Pubmed]
  19. Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Vargas-Roig, L.M., Gago, F.E., Tello, O., Aznar, J.C., Ciocca, D.R. Int. J. Cancer (1998) [Pubmed]
  20. Inhibition of DNA repair and the enhancement of cytotoxicity of alkylating agents. Frankfurt, O.S. Int. J. Cancer (1991) [Pubmed]
  21. Radioimmunoassay of bleomycin in plasma and urine. Teale, J.D., Clough, J.M., Marks, V. Br. J. Cancer (1977) [Pubmed]
  22. Combination chemotherapy as an adjuvant treatment in operable breast cancer. Bonadonna, G., Brusamolino, E., Valagussa, P., Rossi, A., Brugnatelli, L., Brambilla, C., De Lena, M., Tancini, G., Bajetta, E., Musumeci, R., Veronesi, U. N. Engl. J. Med. (1976) [Pubmed]
  23. Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy. Reece, D.E., Connors, J.M., Spinelli, J.J., Barnett, M.J., Fairey, R.N., Klingemann, H.G., Nantel, S.H., O'Reilly, S., Shepherd, J.D., Sutherland, H.J. Blood (1994) [Pubmed]
  24. Improved prognosis for patients with mediastinal lymphoblastic lymphoma. Weinstein, H.J., Vance, Z.B., Jaffe, N., Buell, D., Cassady, J.R., Nathan, D.G. Blood (1979) [Pubmed]
  25. Long-term effects of chemotherapy in patients with testicular cancer. Osanto, S., Bukman, A., Van Hoek, F., Sterk, P.J., De Laat, J.A., Hermans, J. J. Clin. Oncol. (1992) [Pubmed]
  26. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study. Long, H.J., Bundy, B.N., Grendys, E.C., Benda, J.A., McMeekin, D.S., Sorosky, J., Miller, D.S., Eaton, L.A., Fiorica, J.V. J. Clin. Oncol. (2005) [Pubmed]
  27. Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum. Ikuno, N., Soda, H., Watanabe, M., Oka, M. J. Natl. Cancer Inst. (1995) [Pubmed]
  28. Cyclophosphamide and thiotepa with autologous bone marrow transplantation in patients with solid tumors. Eder, J.P., Antman, K., Elias, A., Shea, T.C., Teicher, B., Henner, W.D., Schryber, S.M., Holden, S., Finberg, R., Chritchlow, J. J. Natl. Cancer Inst. (1988) [Pubmed]
  29. Tritiated thymidine labeling index and response in human breast cancer. Sulkes, A., Livingston, R.B., Murphy, W.K. J. Natl. Cancer Inst. (1979) [Pubmed]
  30. Antitumor and toxic effects of combination chemotherapy with bleomycin and a phenothiazine anticalmodulin agent. Hait, W.N., Lazo, J.S., Chen, D.L., Gallichio, V.S., Filderman, A.E. J. Natl. Cancer Inst. (1988) [Pubmed]
  31. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia. Lamy, T., Liu, J.H., Landowski, T.H., Dalton, W.S., Loughran, T.P. Blood (1998) [Pubmed]
  32. Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas. van der Zee, A.G., Hollema, H., Suurmeijer, A.J., Krans, M., Sluiter, W.J., Willemse, P.H., Aalders, J.G., de Vries, E.G. J. Clin. Oncol. (1995) [Pubmed]
  33. Clinical relevance of the lung resistance protein in diffuse large B-cell lymphomas. Filipits, M., Jaeger, U., Simonitsch, I., Chizzali-Bonfadin, C., Heinzl, H., Pirker, R. Clin. Cancer Res. (2000) [Pubmed]
  34. Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer. Ogino, S., Meyerhardt, J.A., Cantor, M., Brahmandam, M., Clark, J.W., Namgyal, C., Kawasaki, T., Kinsella, K., Michelini, A.L., Enzinger, P.C., Kulke, M.H., Ryan, D.P., Loda, M., Fuchs, C.S. Clin. Cancer Res. (2005) [Pubmed]
  35. Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma. Filipits, M., Jaeger, U., Pohl, G., Stranzl, T., Simonitsch, I., Kaider, A., Skrabs, C., Pirker, R. Clin. Cancer Res. (2002) [Pubmed]
  36. Adriamycin and enhanced radiation reaction in normal esophagus and skin. Greco, F.A., Brereton, H.D., Kent, H., Zimbler, H., Merrill, J., Johnson, R.E. Ann. Intern. Med. (1976) [Pubmed]
  37. Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis. Doll, D.C., List, A.F., Greco, F.A., Hainsworth, J.D., Hande, K.R., Johnson, D.H. Ann. Intern. Med. (1986) [Pubmed]
  38. Aggressive treatment for postcardiac transplant lymphoproliferation. Swinnen, L.J., Mullen, G.M., Carr, T.J., Costanzo, M.R., Fisher, R.I. Blood (1995) [Pubmed]
  39. High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy. Reece, D.E., Barnett, M.J., Shepherd, J.D., Hogge, D.E., Klasa, R.J., Nantel, S.H., Sutherland, H.J., Klingemann, H.G., Fairey, R.N., Voss, N.J. Blood (1995) [Pubmed]
  40. Combination of irinotecan and etoposide for treatment of refractory or relapsed small-cell lung cancer. Masuda, N., Matsui, K., Negoro, S., Takifuji, N., Takeda, K., Yana, T., Kobayashi, M., Hirashima, T., Kusunoki, Y., Ushijima, S., Kawase, I., Tada, T., Sawaguchi, H., Fukuoka, M. J. Clin. Oncol. (1998) [Pubmed]
WikiGenes - Universities